Search results for: Determining Value
Filter search results
Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK
1 March 2015
…ability to monitor uptake, identify variation in access and analyse the value of medicines in routine practice. Moreover, the demand by decision-makers and regulators for ‘real world data’ (data collected…
Making Outcome-Based Payment a Reality in the NHS. Phase Two: Practical Considerations
1 December 2021
…published the results of a research study describing how OBP could help accelerate patient access to some new medicines, ensure close monitoring of real-world patient benefits, promote value for money…
A Note on the Relationship Between Age and Health-related Quality of Life Assessment
12 December 2018
…a comparison between the differences in TTO values (i.e. differences between values obtained from the oldest respondents and those obtained from younger age groups) and estimates of minimum clinically important…
Recommendations for Making Outcome-based Payments a Reality in the NHS: An Application to Cancer Drugs
21 February 2019
…patient outcomes and drive value for the health service – taking into consideration the existing capabilities as well as the potential for future indicators to be developed. The research report…
Setting the Right Discount Rate for HTA in the Slovak Republic
21 May 2023
…care less about future outcomes (for example, having better health today is generally preferred to having better health in 10 years’ time). To reflect this, health economic evaluations value present…
Abolishing Pharmaceutical Rebates in the US? Looking at the Trade-Offs
12 March 2019
…be downloaded from the ICER website here. Cole, A., Towse, A., Segel C.S., Henshall, C., Pearson, S.D., 2019. Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for…
OHE Lunchtime Seminar: Health Years in Total (HYT): A New Health Objective Function for Cost-effectiveness Analysis
23 July 2019, 11:00pm
…public decision making on health care (e.g. Medicare). Alternatives to QALY (such as Equal Value of Life, EVL) have not gained traction as their use raises other efficiency issues. For…
OHE Annual Lecture Webinar 2020: How Should the World Pay for a COVID-19 Vaccine?
24 June 2020, 11:00pm
…be paid for, in particular: That patents should be “bought out” either for a price or “prize” that reflects value (or some share of it) or on a cost reimbursement…
Measurement of Health
1 June 1985
…importance of demonstrating that this expenditure is giving value for money, both in… Expenditure on health care is continuing to rise in all Western countries, both in total and as…